SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-010427
Filing Date
2024-04-01
Accepted
2024-04-01 17:25:13
Documents
15
Period of Report
2024-04-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vtgn20240401_8k.htm   iXBRL 8-K 21476
2 EXHIBIT 99.1 ex_648753.htm EX-99.1 14641
  Complete submission text file 0001437749-24-010427.txt   173415

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vtgn-20240401.xsd EX-101.SCH 3408
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtgn-20240401_def.xml EX-101.DEF 11423
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtgn-20240401_lab.xml EX-101.LAB 15309
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtgn-20240401_pre.xml EX-101.PRE 11583
18 EXTRACTED XBRL INSTANCE DOCUMENT vtgn20240401_8k_htm.xml XML 2837
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 24811134
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)